Literature DB >> 7758799

Tau protein in Alzheimer's disease.

M Goedert1, R Jakes, M G Spillantini, R A Crowther, P Cohen, E Vanmechelen, A Probst, J Götz, K Bürki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7758799     DOI： 10.1042/bst0230080

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN： 0300-5127            Impact factor:   5.407


× No keyword cloud information.
  10 in total

1.  Recent advances in the development of immunotherapies for tauopathies.

Authors:  Kiren Ubhi; Eliezer Masliah
Journal:  Exp Neurol       Date:  2010-10-21       Impact factor: 5.330

2.  Astrocytic changes with aging and Alzheimer's disease-type pathology in chimpanzees.

Authors:  Emily L Munger; Melissa K Edler; William D Hopkins; John J Ely; Joseph M Erwin; Daniel P Perl; Elliott J Mufson; Patrick R Hof; Chet C Sherwood; Mary Ann Raghanti
Journal:  J Comp Neurol       Date:  2019-01-07       Impact factor: 3.215

3.  Pre-assembled tau filaments phosphorylated by GSK-3b form large tangle-like structures.

Authors:  Carolyn A Rankin; Qian Sun; T Chris Gamblin
Journal:  Neurobiol Dis       Date:  2008-07-16       Impact factor: 5.996

4.  Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease.

Authors:  D M Wilson; L I Binder
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

Review 5.  Small-molecule PET Tracers for Imaging Proteinopathies.

Authors:  Chester A Mathis; Brian J Lopresti; Milos D Ikonomovic; William E Klunk
Journal:  Semin Nucl Med       Date:  2017-07-13       Impact factor: 4.446

Review 6.  Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer's disease.

Authors:  Lezanne Ooi; Kuldip Sidhu; Anne Poljak; Greg Sutherland; Michael D O'Connor; Perminder Sachdev; Gerald Münch
Journal:  J Neural Transm (Vienna)       Date:  2012-06-13       Impact factor: 3.575

Review 7.  Tau function and dysfunction in neurons: its role in neurodegenerative disorders.

Authors:  Jesús Avila; Filip Lim; Francisco Moreno; Carlos Belmonte; A Claudio Cuello
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

8.  Subcellular Changes in Bridging Integrator 1 Protein Expression in the Cerebral Cortex During the Progression of Alzheimer Disease Pathology.

Authors:  Stephanie L Adams; Kathy Tilton; James A Kozubek; Sudha Seshadri; Ivana Delalle
Journal:  J Neuropathol Exp Neurol       Date:  2016-06-26       Impact factor: 3.685

9.  p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide.

Authors:  Kathleen I Seyb; Sabah Ansar; Guibin Li; Jennifer Bean; Mary L Michaelis; Rick T Dobrowsky
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

10.  Interplay of Ferritin Accumulation and Ferroportin Loss in Ageing Brain: Implication for Protein Aggregation in Down Syndrome Dementia, Alzheimer's, and Parkinson's Diseases.

Authors:  Animesh Alexander Raha; Anwesha Biswas; James Henderson; Subhojit Chakraborty; Anthony Holland; Robert P Friedland; Elizabeta Mukaetova-Ladinska; Shahid Zaman; Ruma Raha-Chowdhury
Journal:  Int J Mol Sci       Date:  2022-01-19       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.